Atrix to be issued additional U.S. patent for BEMA Technology.

0 Comments | M2 Presswire, April, 2000

M2 PRESSWIRE-11 April 2000-ATRIX LABORATORIES: Atrix to be issued additional U.S. patent for BEMA Technology (C)1994-2000 M2 COMMUNICATIONS LTD RDATE:10042000 FORT COLLINS, Colorado -- Atrix Laboratories, Inc. (Nasdaq NM: ATRX) announced that the U.S. Patent and Trademark Office has issued a formal Notice of Allowance, indicating that Atrix will be issued a patent that substantially extends the company's protection of the Bioerodible Mucoadhesive (BEMA) technology.

BEMA is a unique, highly versatile pre-formed film designed for both systemic and local drug delivery across the oral mucosal membranes. BEMA can be formulated to deliver drugs at different time intervals and rapidly becomes unnoticeable as it erodes away. Atrix already holds one U.S....